IB
iShares Biotechnology ETF (IBB)
NASDAQ·Financial Services·Asset Management
$211.91
+1.55%
Mkt Cap $10.73B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$217.35
Range $147.42 – $255.15
Implied Upside
+2.6%
Consensus $217.35 vs current $211.91